全文获取类型
收费全文 | 1889篇 |
免费 | 132篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 96篇 |
妇产科学 | 41篇 |
基础医学 | 305篇 |
口腔科学 | 32篇 |
临床医学 | 217篇 |
内科学 | 414篇 |
皮肤病学 | 15篇 |
神经病学 | 57篇 |
特种医学 | 346篇 |
外科学 | 250篇 |
综合类 | 27篇 |
一般理论 | 1篇 |
预防医学 | 49篇 |
眼科学 | 13篇 |
药学 | 57篇 |
中国医学 | 6篇 |
肿瘤学 | 88篇 |
出版年
2021年 | 17篇 |
2020年 | 19篇 |
2019年 | 12篇 |
2018年 | 40篇 |
2017年 | 21篇 |
2016年 | 28篇 |
2015年 | 37篇 |
2014年 | 48篇 |
2013年 | 51篇 |
2012年 | 44篇 |
2011年 | 45篇 |
2010年 | 48篇 |
2009年 | 81篇 |
2008年 | 58篇 |
2007年 | 47篇 |
2006年 | 56篇 |
2005年 | 39篇 |
2004年 | 42篇 |
2003年 | 40篇 |
2002年 | 46篇 |
2001年 | 50篇 |
2000年 | 44篇 |
1999年 | 42篇 |
1998年 | 65篇 |
1997年 | 66篇 |
1996年 | 75篇 |
1995年 | 61篇 |
1994年 | 49篇 |
1993年 | 51篇 |
1992年 | 42篇 |
1991年 | 31篇 |
1990年 | 36篇 |
1989年 | 61篇 |
1988年 | 50篇 |
1987年 | 46篇 |
1986年 | 57篇 |
1985年 | 39篇 |
1984年 | 25篇 |
1983年 | 18篇 |
1982年 | 30篇 |
1981年 | 20篇 |
1979年 | 12篇 |
1977年 | 19篇 |
1976年 | 25篇 |
1975年 | 29篇 |
1974年 | 25篇 |
1973年 | 12篇 |
1972年 | 21篇 |
1971年 | 19篇 |
1968年 | 12篇 |
排序方式: 共有2028条查询结果,搜索用时 15 毫秒
1.
AIMS: To examine the effects of agents that alter potassium adenosine triphosphate (KATP) channel activity in beta-cells on cognitive function and counterregulatory hormone responses during acute hypoglycaemia, given the physiological similarities between the pancreatic beta-cell and the hypothalamic glucose-sensitive neurones (GSN) and the widespread distribution of sulphonylurea receptors in neuronal cells throughout the brain. METHODS: Ten healthy males were studied on four occasions and in random order underwent three stepped hypoglycaemic (plasma glucose aims: 3.4, 2.8, 2.4 mmol/l) and one euglycaemic (plasma glucose aim: 5 mmol/l) insulin clamps. Prior to each hypoglycaemic study, volunteers received either 10 mg glibenclamide, or 5 mg/kg diazoxide or placebo orally. Cognitive function, symptom scores and counterregulatory hormone responses were measured at each glycaemic level. RESULTS: There was no statistically significant effect of either drug on the symptoms generated or the counterregulatory hormonal response during hypoglycaemia. However, cognitive function was better preserved during hypoglycaemia in the glibenclamide-treated arm, particularly four-choice reaction time which deteriorated at a plasma glucose 2.5 mmol/l compared with 3.0 mmol/l with diazoxide (P = 0.015) and 2.9 mmol/l with placebo (P = 0.114). CONCLUSIONS: Single doses of pharmacological agents which alter membrane KATP channel activity do not affect the counterregulatory response to hypoglycaemia but may modify cognitive function during cerebral glucopenia. The unexpected effects of glibenclamide on cortical function suggest a novel action of sulphonylureas that warrants further investigation. 相似文献
2.
Current trend in the treatment of Hodgkin's disease 总被引:1,自引:0,他引:1
M Tubiana J L Amiel M Hayat M Henry-Amar J M Cosset J P Droz P Carde 《Radiation Medicine》1983,1(3):221-229
The analysis of three subsequent randomized trials carried out within the frame of the European Organization for Research on Cancer (E.O.R.T.C.) enables to define a strategy for the staging and the treatment of early stages of Hodgkin's disease. Several prognostic factors were identified by multivariate analyses: 1) erythrocyte sedimentation rate, which has a greater impact on relapse-free survival than systemic symptoms but which can be combined with them; the combination of the two is a more powerful prognostic indicator than ESR alone; 2) the number of involved lymphatic areas: patients with one or two lymphatic areas involved (CS I and II2) have a better outcome than stage II patients with 3 or more areas involved (CS II3). Patients with favorable prognostic indicators are submitted to staging laparotomy because for them spleen involvement has a pejorative impact. For patients with unfavorable indicators, the spleen involvement has little prognostic significance and therefore those patients who need, anyway, an aggressive treatment do not undergo staging laparotomy. Patients with favorable prognostic indicators and negative staging laparotomy can be treated by radiotherapy alone, patients with positive laparotomy or patients with unfavorable prognostic indicators are treated by combination of multiple chemotherapy and radiotherapy. 相似文献
3.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
4.
J S Wayne D Amiel M K Kwan S L Woo A Fierer M H Meyers 《Acta orthopaedica Scandinavica》1990,61(6):539-545
We have studied long-term (to 60 days) effects of 4 degrees C storage in culture media on the histologic, mechanical, and chemical properties of the cartilage from osteochondral shell allografts from the dog. The structural integrity of the cartilage matrix was intact up to 60 days of storage, for the mechanical properties represented by the aggregate modulus and apparent permeability remained normal. These data are supported by normal safranin-O staining as well as normal glycosaminoglycan content and total collagen concentration. However, chondrocyte viability, as assessed by 35SO4 uptake and hematoxylin and eosin preparations, decreased dramatically with time. We believe that the longer storage to 60 days is not indicated, unless conditions can be modified to maintain cell viability. 相似文献
5.
6.
7.
8.
9.
10.